WHO forecasts Ebola vaccine progress
A promising vaccine candidate has been developed against the rare "Bondi Bogu" strain of Ebola virus, for which there is currently no approved vaccine or treatment. The new vaccine is based on the rVSV platform and can be stored at normal temperatures for several months, making distribution easier and reducing costs in remote areas. The World Health Organization is highly optimistic about the vaccine's potential success in combating the outbreak in the Democratic Republic of the Congo, where the health authorities have reported over 3,532 cases and 1,556 deaths—a second-largest outbreak recorded worldwide.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)